1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin. 2001; 51:15–36. PMID:
11577478.
Article
2. Bae JM, Won YJ, Jung KW, Park JG. Annual report of the Korea central cancer registry program 2000: based data from 131 hospitals. Cancer Res Treat. 2002; 34:77–83.
3. Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, Kubista TP, Poon MA, Meyers WC, Mailliard JA. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med. 1991; 324:709–715. PMID:
1997835.
Article
4. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: A systematic overview of 8,507 patients from 22 randomised trials. Lancet. 2001; 358:1291–1304. PMID:
11684209.
5. O'Connell MJ, Martenson JA, Wieand HS, Krook JE, Macdonald JS, Haller DG, Mayer RJ, Gunderson LL, Rich TA. Improving adjuvant therapy for rectal cancer by combining protracted-infusion 5-FU with radiation therapy after curative surgery. N Engl J Med. 1994; 331:502–507. PMID:
8041415.
6. Neri B, Gemelli MT, Pantalone D, Pernice ML, Agostino I, Scatizzi M, Siliani GM, Bartolini P, Andreoli F. Results of leucovorin and doxifluridine oral regimen in the treatment of metastatic colorectal caner. Anticancer Drugs. 1998; 9:599–602. PMID:
9773803.
7. Merkel S, Mansmann U, Papadopoulos T, Wittekind C, Hohenberger W, Hermanek P. The prognostic inhomogeneity of colorectal carcinomas Stage III: a proposal for subdivision of Stage III. Cancer. 2001; 92:2754–2759. PMID:
11753948.
8. American Joint Committee on Cancer. AJCC cancer staging manual. 2002. 6th ed. New York: Springer-Verlag;p. 113–123.
9. National Institutes of Health Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990; 264:1444–1450. PMID:
2202842.
10. Fisher B, Wolmark N, Rockette H, Redmond C, Deutsch M, Wickerham DL, Fisher ER, Caplan R, Jones J, Lerner H. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst. 1988; 80:21–29. PMID:
3276900.
11. Tepper JE, O'Connell M, Niedzwiecki D, Hollis DR, Benson AB III, Cummings B, Gunderson LL, Macdonald JS, Martenson JA, Mayer RJ. Adjuvant therapy in rectal cancer: Analysis of stage, sex, and local control?final report of intergroup 0114. J Clin Oncol. 2002; 20:1744–1750. PMID:
11919230.
Article
12. International multicentre pooled analysis of colon cancer trials (IMPACT) investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet. 1995; 345:939–944. PMID:
7715291.
13. Meta-analysis Group in Cancer. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol. 1998; 16:301–308. PMID:
9440757.
14. Liu G, Franssen E, Fitch MI, Warner E. Patient preference for oral versus intravenous palliative chemotherapy. J Clin Oncol. 1997; 15:110–115. PMID:
8996131.
15. Bollag W, Hartmann HR. Tumor inhibitory effects of a new fluorouracil derivative: 5'-deoxy-5-fluorouridine. Eur J Cancer. 1980; 16:427–432. PMID:
6447071.
Article
16. Kono A, Hara Y, Suga S, Karube Y, Matsushima Y, Ishitsuka H. Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors. Chem Pharm Bull. 1983; 31:175–178. PMID:
6221809.
Article
17. Kim NK, Min JS, Park JK, Yun SH, Sung JS, Jung HC, Roh JK. Intravenous 5-FU versus oral doxifluridine as preoperative concurrent chemoradiation for locally advanced rectal cancer: Prospective randomized trials. Jpn J Clin Oncol. 2001; 31:25–29. PMID:
11256837.
18. Armstroung RD, Cadman E. 5'-Deoxy-5-fluorouridine selective toxicity for human tumor cells compared to human bone marrow. Cancer Res. 1983; 43:2525–2528. PMID:
6221792.
19. Tang R, Wang JY, Chen JS, Chang-Chien CR, Tang S, Lin SE, You YT, Hsu KC, Ho YS, Fan HA. Survival impact of lymph node metastasis in TNM stage III carcinoma of the colon and rectum. J Am Coll Surg. 1995; 180:705–712. PMID:
7773484.
20. Greene FL, Stewart AK, Norton HJ. A new TNM staging strategy for node-positive (stage III) colon cancer: An analysis of 50,042 patients. Ann Surg. 2002; 236:416–421. PMID:
12368669.
21. Greene FL, Stewart AK, Norton HJ. A new TNM staging strategy for node-positive (stage III) rectal cancer: An analysis of 5,988 patients. Proc Am Soc Clin Oncol. 2003; 22:251.